BridgeBio Oncology Therapeutics

IPO

BridgeBio Oncology Therapeutics (BBOT) | Best-in-RAS

About

Clinical-stage oncology company developing bioavailable small molecule inhibitors targeting RAS-dependent cancers in precision oncology.

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Biopharmaceutical services company

Specialty pharmaceutical company

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...